READ THE NEWS ON ONE CLICKhttp://www.theoneclickgroup.co.uk1. GlaxoSmithKline Withdraws Pandemrix Swine Flu Vaccine After Adverse Reactions And DeathManitoba's Chief Medical Officer of Health,Dr Joel KettnerMore than 100,000 doses of the H1N1 vaccine are being withdrawn across the country, after Manitoba health officials announced Thursday they'd noticed a higher-than-usual number of
Reach out and excell! At GlaxoSmithKline, we dedicated ourselves to provide Pharmaceutical and Consumer Healthcare products to help millions of people to improve the quality of human life by enabling people to do more, feel better and live longer. That’s why we work at GSK! Professional Sales Representatives (Code: PSR) Reports directly to District Sales Manager, the incumbent [...]
Connecting the Dots in the New World Order (Free subscription) | yesterday
A new development in the H1N1 Vaccine Saga is unfolding in Canada. Whereas health officials are pushing for an acceleration of the vaccination program, there is evidence of so-called "unusual adverse reactions" including three recently recorded deaths directly resulting from the vaccine. In the meantime, health authorities have called for the withdrawal of 170,000 (higher risk) doses of the...
11-20-09 Source The German Professional Assocation of Environmental Doctors, (Deutschen Berufsverbands der Umweltmediziner) issued a press release on November 9th warning of the “significant health risks” of using GlaxoSmithKline’s Pandemrix for mass vaccinations in view of the lack of data on its safety, especially for pregnant women and children. The press release predicted the...
eldavojohn writes "Almost 6 years ago we discussed a vaccine to help people quit smoking as it entered human clinical trials. Now it looks like the finishing touches have been put on a deal that will go into effect once phase III testing of the drug now called NicVAX is completed. NicVAX was developed by Nabi Biopharmaceuticals, who have agreed to license it to GlaxoSmithKline Biologicals; it...
GlaxoSmithKline will begin manufacturing its treatment for flu, Relenza, in China to supply China’s domestic market. GSK received approval of the drug in September from the SFDA. Relenza, like Tamiflu from Roche, aims at reducing both the severity and the duration of flu symptoms, though some resistance to the drugs seems to be evident. [More...]
In a change of tack, Europe's drugs watchdog said today that giving a single dose of GlaxoSmithKline's Pandemrix or Novartis's Focetria swine flu vaccines would suffice for most people.
Samir Ghodbane, Ph.D. , has been appointed as the new general manager of CMC services and CTM manufacturing at Frontage . Dr. Ghodbane has extensive experience and expertise in product development and technical operations spanning the complete product development cycle, as well as a comprehensive understanding of branded and generic pharmaceutical environments. He has led drug development and technical...
The German Medicine Products Commission of German Pharmacists (AMK) has issued an urgent report warning that foreign particles have been observed on two occasions when the components of GlaxoSmithKline's Pandemrix swine flu vaccine -- the antigen suspension and adjuvant emulsion -- have been mixed. The AMK has sent samples to the Central Laboratory of German Pharmacists to be investigated. http://www.abda.de/2400.html...
London, U.K. (AHN) – Pharmaceutical firms GlaxoSmithKline (GSK) and Nabi Biopharmaceuticals have entered into a $540 million exclusive licensing agreement to develop and market an anti-smoking vaccine. Under the deal, GSK will pay an upfront fee of $40 million to in-license Nabi’s NicVAX worldwide and use the latter’s technology in developing its own anti-nicotine vaccine. GSK [...]...
Joe Theismann rolls to his right as well as his left in our interview at FedEx Field. Image via www.tristarproductions.com View full size photo » As I said earlier this week, we can't simply reserve our complaints about the current debacle surrounding our team for weeks when we lose. However, during Dallas Week, we can tone it down slightly so that the focus of the week remains firmly where it...
Robert F. Kennedy, Jr. - Deadly Immunity Click either link below to read the full article: Read article at Rollingstone.com Read article at Salon.com In June 2000, a group of top government scientists and health officials gathered for a meeting at the isolated Simpsonwood conference center in Norcross, Georgia. Convened by the Centers for Disease Control and Prevention, the meeting was held at this...
The FDA's Vaccines and Related Biological Products Advisory Committee today will determine whether Protein Sciences' flu vaccine FluBlok, which can be produced in less than two months by inserting flu genes into an insect virus and growing it in caterpillar ovary cells, warrants approval. FluBlok can be produced in a third of the time it takes larger drugmakers, including Sanofi-Aventis, GlaxoSmithKline...
Driscoll More than 90 people say GlaxoSmithKline was wrong in selling a diabetes drug without first warning of potential serious side effects from which they or their deceased relatives suffered. Lead plaintiff Carmen Colon, along with 97 others, filed suit Nov. 12 in St. Clair County against the drug company. John J. Driscoll of St. Louis, Christopher Cueto of Belleville and Robert L. Salim of Natchitoches,...
From Canada.com: Criminal gangs are making millions of dollars out of the H1N1 flu pandemic by selling fake flu drugs over the internet, a web security firm said on Monday. Sophos, a British security software firm said it had intercepted hundreds of millions of fake pharmaceutical spam adverts and websites this year, many of them trying to sell counterfeit antiviral drugs like Tamiflu to worried customers....
Videos
